These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26089018)

  • 1. A social path to functioning in schizophrenia: From social self-efficacy through negative symptoms to social functional capacity.
    Vaskinn A; Ventura J; Andreassen OA; Melle I; Sundet K
    Psychiatry Res; 2015 Aug; 228(3):803-7. PubMed ID: 26089018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A path model investigation of neurocognition, theory of mind, social competence, negative symptoms and real-world functioning in schizophrenia.
    Couture SM; Granholm EL; Fish SC
    Schizophr Res; 2011 Feb; 125(2-3):152-60. PubMed ID: 20965699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia.
    Grant PM; Beck AT
    Schizophr Bull; 2009 Jul; 35(4):798-806. PubMed ID: 18308717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment.
    Lysaker PH; Kukla M; Dubreucq J; Gumley A; McLeod H; Vohs JL; Buck KD; Minor KS; Luther L; Leonhardt BL; Belanger EA; Popolo R; Dimaggio G
    Schizophr Res; 2015 Oct; 168(1-2):267-72. PubMed ID: 26164820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: testing mediator and moderator effects.
    Nakagami E; Xie B; Hoe M; Brekke JS
    Schizophr Res; 2008 Oct; 105(1-3):95-104. PubMed ID: 18715756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures.
    Bowie CR; Leung WW; Reichenberg A; McClure MM; Patterson TL; Heaton RK; Harvey PD
    Biol Psychiatry; 2008 Mar; 63(5):505-11. PubMed ID: 17662256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reexamination of the relationships among neurocognition, self-defeatist beliefs, experiential negative symptoms, and social functioning in a sample of patients diagnosed with chronic schizophrenia and schizoaffective disorder.
    Lee KH; Yu CH
    BMC Psychiatry; 2024 Aug; 24(1):559. PubMed ID: 39138483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome.
    Mancuso F; Horan WP; Kern RS; Green MF
    Schizophr Res; 2011 Feb; 125(2-3):143-51. PubMed ID: 21112743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascading and combined effects of cognitive deficits and residual symptoms on functional outcome in schizophrenia - A path-analytical approach.
    Bhagyavathi HD; Mehta UM; Thirthalli J; Kumar CN; Kumar JK; Subbakrishna DK; Gangadhar BN
    Psychiatry Res; 2015 Sep; 229(1-2):264-71. PubMed ID: 26208988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.
    Jordan G; Lutgens D; Joober R; Lepage M; Iyer SN; Malla A
    J Clin Psychiatry; 2014 Jun; 75(6):e566-72. PubMed ID: 25004197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dysfunctional attitudes in models of negative symptoms and functioning in schizophrenia.
    Quinlan T; Roesch S; Granholm E
    Schizophr Res; 2014 Aug; 157(1-3):182-9. PubMed ID: 24924405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder.
    Bowie CR; Depp C; McGrath JA; Wolyniec P; Mausbach BT; Thornquist MH; Luke J; Patterson TL; Harvey PD; Pulver AE
    Am J Psychiatry; 2010 Sep; 167(9):1116-24. PubMed ID: 20478878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.
    Ventura J; Welikson T; Ered A; Subotnik KL; Keefe RSE; Hellemann GS; Nuechterlein KH
    Early Interv Psychiatry; 2020 Feb; 14(1):106-114. PubMed ID: 31183960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How neurocognition and social cognition influence functional change during community-based psychosocial rehabilitation for individuals with schizophrenia.
    Brekke JS; Hoe M; Long J; Green MF
    Schizophr Bull; 2007 Sep; 33(5):1247-56. PubMed ID: 17255120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social cognition in schizophrenia: relationships with neurocognition and negative symptoms.
    Sergi MJ; Rassovsky Y; Widmark C; Reist C; Erhart S; Braff DL; Marder SR; Green MF
    Schizophr Res; 2007 Feb; 90(1-3):316-24. PubMed ID: 17141477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia.
    González-Blanch C; Perez-Iglesias R; Pardo-García G; Rodríguez-Sánchez JM; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2010 Jun; 40(6):935-44. PubMed ID: 19751542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.
    Perlick DA; Rosenheck RA; Kaczynski R; Bingham S; Collins J
    Schizophr Res; 2008 Feb; 99(1-3):192-9. PubMed ID: 17851042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis.
    Glenthøj LB; Jepsen JR; Hjorthøj C; Bak N; Kristensen TD; Wenneberg C; Krakauer K; Nordentoft M; Fagerlund B
    Acta Psychiatr Scand; 2017 Mar; 135(3):250-258. PubMed ID: 27988937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subjective and objective quality of life in schizophrenia.
    Narvaez JM; Twamley EW; McKibbin CL; Heaton RK; Patterson TL
    Schizophr Res; 2008 Jan; 98(1-3):201-8. PubMed ID: 17919890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.